CVM : Summary for Cel-Sci Corporation Common Stoc - Yahoo Finance

U.S. Markets closed

CEL-SCI Corporation (CVM)

NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
0.10+0.00 (+2.43%)
At close: 4:02PM EST

0.10 0.00 (3.55%)
After hours: 5:24PM EST

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close0.10
Bid0.00 x
Ask0.00 x
Day's Range0.10 - 0.11
52 Week Range0.06 - 0.66
Avg. Volume3,042,542
Market Cap19.34M
PE Ratio (TTM)-1.14
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire10 hours ago

    CEL-SCI Scientist Presents New Findings for Rheumatoid Arthritis Treatment Vaccine at Conference

    CEL-SCI Corporation today announced that Dr. Daniel Zimmerman, its Senior V.P of Research, Cellular Immunology, presented data with a LEAPS Rheumatoid Arthritis therapeutic vaccine at Madridge‘s International Conference on Vaccines held in Baltimore, MD on February 20-22, 2017.

  • Business Wire4 days ago

    CEL-SCI Announces $1.0 Million Registered Direct Offering

    CEL-SCI Corporation today announced it has entered into a definitive agreement with institutional investors for an offering of shares of common stock with gross proceeds of approximately $1.0 million in a registered direct offering.

  • Associated Press12 days ago

    Cel-Sci posts 1Q profit

    On a per-share basis, the Vienna, Virginia-based company said it had net income of 1 cent. The cancer immunotherapy company posted revenue of $7,300 in the period. Its adjusted revenue was $7,000. In the ...